Al-Dawaa Medical Services Company

SR 38.18As of Sun 8 Nov 2026, 12:00 UTC
Tadawul:4163Healthcare
Country Saudi Arabia
PE (Fwd) •••
TSR 5Y CAGR (10.69%)
Div yield 6.60%
ROE 12.68%
Medical (Pharmaceuticals)
Beta (5Y) (0.03)
PE TTM 17.78
TSR TTM (38.85%)
Mkt cap SR 3.245B
ROIC 8.37%
SE Grade™
Value
Quality
Moat
Consensus
Reference
SR 46
21.34%
(61.01%)
Buy 11|12|12|1|3
4Q25
1Q26
2Q26
3Q26
Earnings per shareSR
0.86
0.91
1.00
1.10
36.29%
38.30%
42.69%
40.38%
RevenueSR M
288.3
299.1
292.8
287.4
12.97%
12.01%
3.62%
(1.49%)
Peers (US$874.1M)
Cap (US$)
PE
3.324B
15.14x
65.44M
35.24x
Capital
TTM
5Y
10Y
Leveragex
2.088
0.046
0.043
EBIT/Intx
0.701
0.220
0.237
Own earn%
33.14
(12.04)
(12.74)
Sh yield%
16.98
48.05
49.26
Owners
Insiders/Inst%
9.45
43.41
Short interest%
1.88
SBC / revenue%
3.74
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
19–26
$1 testx
—
Incr. ROIC%
5